LYMPHOCYTE CYTOTOXICITY IN BLADDER CANCER NO REQUIREMENT FOR THYMUS-DERIVED EFFECTOR CELLS ?
- 1 May 1973
- journal article
- Published by Elsevier in The Lancet
- Vol. 301 (7812), 1085-1088
- https://doi.org/10.1016/s0140-6736(73)90396-6
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- SURFACE MARKERS ON HUMAN T AND B LYMPHOCYTESThe Journal of Experimental Medicine, 1972
- Cellular immunity to human urinary bladder carcinoma. II. Effect of surgery and preoperative irradiationInternational Journal of Cancer, 1972
- Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapyInternational Journal of Cancer, 1972
- CELLS MEDIATING SPECIFIC IN VITRO CYTOTOXICITYThe Journal of Experimental Medicine, 1972
- Separation of Cells According to Surface Antigens by the Use of Antibody‐Coated Columns. Fractionation of Cells Carrying Immunoglobulins and Blood Group AntigenScandinavian Journal of Immunology, 1972
- Cellular and humoral immune responses to human urinary bladder carcinomasInternational Journal of Cancer, 1970
- Immune response to urinary bladder tumours in manInternational Journal of Cancer, 1970
- AN EXTENSION OF THE51Cr-RELEASE ASSAY FOR THE ESTIMATION OF MOUSE CYTOTOXINSTransplantation, 1968
- SEPARATION OF VIABLE LYMPHOCYTES FROM HUMAN BLOODThe Lancet, 1964
- A New Method for Preparing Buffy Coat‐Poor BloodTransfusion, 1962